Nothing Special   »   [go: up one dir, main page]

Kendall et al., 2002 - Google Patents

Expression analysis of a novel p75NTR signaling protein, which regulates cell cycle progression and apoptosis

Kendall et al., 2002

View HTML
Document ID
12422711248924176739
Author
Kendall S
Goldhawk D
Kubu C
Barker P
Verdi J
Publication year
Publication venue
Mechanisms of Development

External Links

Snippet

Neurotrophin receptor-interacting MAGE (NRAGE) is the most recently identified p75 neurotrophin receptor (p75NTR) intracellular binding protein. Previously, NRAGE over- expression was shown to mediate cell cycle arrest and facilitate nerve growth factor (NGF) …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Similar Documents

Publication Publication Date Title
Kendall et al. Expression analysis of a novel p75NTR signaling protein, which regulates cell cycle progression and apoptosis
Ebens et al. Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons
Prieto et al. Gas6, a ligand for the receptor protein-tyrosine kinase Tyro-3, is widely expressed in the central nervous system
Shibayama et al. Cellular localization of the Trk neurotrophin receptor family in human non-neuronal tissues.
Camuso et al. Pleiotropic effects of BDNF on the cerebellum and hippocampus: Implications for neurodevelopmental disorders
Korsching et al. Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation.
Woodruff et al. Oligodendrocyte development in the spinal cord and telencephalon: common themes and new perspectives
Maxeiner et al. Spatiotemporal transcription of connexin45 during brain development results in neuronal expression in adult mice
Naveilhan et al. Expression and regulation of GFRα3, a glial cell line-derived neurotrophic factor family receptor
Takebayashi et al. Dynamic expression of basic helix-loop-helix Olig family members: implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3
Jia et al. Slit/Robo signaling is necessary to confine early neural crest cells to the ventral migratory pathway in the trunk
US20040214766A1 (en) VEGF-C or VEGF-D materials and methods for treatment of neuropathologies
Li et al. Upregulation of gap junction connexin 32 with epileptiform activity in the isolated mouse hippocampus
Calza et al. Thyroid hormone-induced plasticity in the adult rat brain
Li et al. Potential target genes of EMX2 include Odz/Ten-M and other gene families with implications for cortical patterning
McKay et al. The expression of trk B and p75 and the role of BDNF in the developing neuromuscular system of the chick embryo
Le Bras et al. Oligodendrocyte development in the embryonic brain: the contribution of the plp lineage
Ludwig et al. Neurturin Evokes MAPK‐Dependent Upregulation of Egr4 and KCC2 in Developing Neurons
Heller et al. Analysis of function and expression of the chick GPA receptor (GPAR α) suggests multiple roles in neuronal development
Artinger et al. Placodal origin of Brn‐3—expressing cranial sensory neurons
Nakamura et al. Glial expression of fibroblast growth factor‐9 in rat central nervous system
MacLennan et al. In vivo localization and characterization of functional ciliary neurotrophic factor receptors which utilize JAK-STAT signaling
Zaratin et al. Schwann cell overexpression of the GPR7 receptor in inflammatory and painful neuropathies
Zhang et al. Specific expression in mouse mesoderm-and neural crest-derived tissues of a human PDGFRA promoter/lacZ transgene
Iwasaki et al. Expression profiles of inka2 in the murine nervous system